Posts

Cefditoren Pivoxil Amorphous manufactures | Covalent Laboratories

Image
Covalent Laboratories Private Limited , an ISO 9001:2008 & ISO 14001(2004) accreditated pharmaceutical company and WHO GMP certified for all its products, is specialized in the manufacturing of Cephalosporins. It has a wide range of products and is fast expanding to meet the present and future market demands for high value, low volume drugs. Covalent Laboratories Private Limited, an ISO 9001:2008 & ISO 14001(2004) accreditated in manufacturing  Cefditroen Pivoxil Amorphous India ,   pharmaceutical company and WHO GMP certified for all its products, is specialized in the manufacturing of Cefditoren Pivoxil Amorphous India. It has a wide range of products and is fast expanding to meet the present and future market demands for high value, low volume drugs. Covalent Laboratories manufactures the Active Pharmaceutical Ingredient (API) in bulk quantities. Cefditoren Pivoxil Amorphous Indian  Cefixime 2.5 Kg HDP drum DMFs, USDMF KFDA Cefuroxime Axetil A...
Post a Comment
Read more

Cefotaxime Sodium Sterile Suppliers

Image
Covalent Laboratories Private Limited is an ISO 14001:2004, USFDA, KFDA and WHO-GMP certified for all its products. Covalent Laboratories is specialized in the manufacturing of Cephalosporins and its intermediates. Cefotaxime is a third-generation cephalosporin antibiotic. Like other third-generation cephalosporins, this drug in dry powder injectables form, has broad spectrum activity against Gram positive and Gram negative bacteria. In most cases, it is considered to be equivalent to ceftriaxone in terms of safety and efficacy. To reduce the development of drug-resistant bacteria and maintain the effectiveness of Cefotaxime (cefotaxime for injection) for Injection USP and Dextrose Injection and other antibacterial drugs, Cefotaxime (cefotaxime for injection) for Injection USP and Dextrose Injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. x
Post a Comment
Read more